Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curt D Furberg

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
Journal of the American Geriatrics Society|March 28, 2008
Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health StudyCurt D Furberg, Jeanenne J Nelson, Cam Solomon, et al.
Preventive Medicine|October 12, 2010
Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physiciansAnthony J Viera, Stacey L Sheridan, Teresa Edwards, et al.
JAMA|January 8, 2004
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002Randall S Stafford, Curt D Furberg, Stan N Finkelstein, et al.
Clinical Science (London, England : 1979)|December 23, 2011
The causal exposure model of vascular diseaseAllan D Sniderman, Patrick R Lawler, Ken Williams, et al.
The American Journal of Cardiology|June 14, 2002
Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT)G B John Mancini, Michael E Miller, Gregory W Evans, et al.
Circulation|February 28, 2002
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learnedCurt D Furberg, Eric Vittinghoff, Michael Davidson, et al.
JAMA|May 22, 2003
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysisBruce M Psaty, Thomas Lumley, Curt D Furberg, et al.
Pharmacoepidemiology and Drug Safety|June 25, 2009
Time trends in the use of anti-hypertensive medications: results from the Multi-Ethnic Study of AtherosclerosisJoseph A C Delaney, Robyn L McClelland, Curt D Furberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2004
Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?Michael G Shlipak, Catherine Stehman-Breen, Eric Vittinghoff, et al.
Circulation|May 3, 2006
Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health StudyCamille A Pearte, Curt D Furberg, Ellen S O'Meara, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
Journal of the American Geriatrics Society|March 28, 2008
Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health StudyCurt D Furberg, Jeanenne J Nelson, Cam Solomon, et al.
Preventive Medicine|October 12, 2010
Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physiciansAnthony J Viera, Stacey L Sheridan, Teresa Edwards, et al.
JAMA|January 8, 2004
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002Randall S Stafford, Curt D Furberg, Stan N Finkelstein, et al.
Clinical Science (London, England : 1979)|December 23, 2011
The causal exposure model of vascular diseaseAllan D Sniderman, Patrick R Lawler, Ken Williams, et al.
The American Journal of Cardiology|June 14, 2002
Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT)G B John Mancini, Michael E Miller, Gregory W Evans, et al.
Circulation|February 28, 2002
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learnedCurt D Furberg, Eric Vittinghoff, Michael Davidson, et al.
JAMA|May 22, 2003
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysisBruce M Psaty, Thomas Lumley, Curt D Furberg, et al.
Pharmacoepidemiology and Drug Safety|June 25, 2009
Time trends in the use of anti-hypertensive medications: results from the Multi-Ethnic Study of AtherosclerosisJoseph A C Delaney, Robyn L McClelland, Curt D Furberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2004
Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?Michael G Shlipak, Catherine Stehman-Breen, Eric Vittinghoff, et al.
Circulation|May 3, 2006
Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health StudyCamille A Pearte, Curt D Furberg, Ellen S O'Meara, et al.
Pageof 17